Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.90 and traded as low as $0.89. Oxbridge Re shares last traded at $0.9199, with a volume of 6,125 shares traded.
Analysts Set New Price Targets
Separately, Weiss Ratings lowered shares of Oxbridge Re from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.
Read Our Latest Stock Report on Oxbridge Re
Oxbridge Re Trading Up 1.6%
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last released its earnings results on Saturday, February 14th. The insurance provider reported $0.02 earnings per share for the quarter. Oxbridge Re had a negative net margin of 76.47% and a negative return on equity of 33.33%. The firm had revenue of $0.58 million during the quarter.
Institutional Trading of Oxbridge Re
Several institutional investors have recently added to or reduced their stakes in OXBR. J.W. Cole Advisors Inc. bought a new stake in Oxbridge Re during the third quarter valued at $59,000. Virtu Financial LLC acquired a new position in Oxbridge Re during the 3rd quarter valued at approximately $32,000. Henrickson Nauta Wealth Advisors Inc. boosted its position in Oxbridge Re by 100.0% during the 4th quarter. Henrickson Nauta Wealth Advisors Inc. now owns 137,400 shares of the insurance provider’s stock valued at $185,000 after purchasing an additional 68,700 shares during the period. Finally, International Assets Investment Management LLC acquired a new position in Oxbridge Re during the 4th quarter valued at approximately $39,000. Institutional investors own 5.64% of the company’s stock.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
See Also
- Five stocks we like better than Oxbridge Re
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
